Durometer for Measuring Uterine Tone
University of Chicago · NCT06284421
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–50 · Women only
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 20
- US sites recruiting
- 1
- Study start
- February 8, 2024
- Record last updated
- May 6, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study will evaluate the use of a durometer to measure uterine tone in parturients undergoing cesarean delivery.
Being studied: Shore durometer
Conditions: Uterine Tone Disorders; Cesarean Section Complications
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Non-emergent (scheduled) cesarean delivery at University of Chicago Family Birth Center
- Patients ages 18-50
Exclusion Criteria
- Patients undergoing unscheduled (intrapartum) cesarean delivery
- Ages \<18 or >50 years old
- Intrapartum cesarean hysterectomy
- Inability to provide independent, informed consent due to impairment or intellectual disability
- Non-English speaking patients
Recruiting US locations
University of Chicago
Chicago, IL 60637
Site contact: Naida M Cole, MD · 773-702-6700 · nmcole@bsd.uchicago.edu
Study contacts (from the official record)
- Al McAuley · (773) 834-3274 · amcauley1@dacc.uchicago.edu
Similar studies in Illinois
All pregnancy studies in Illinois →- RecruitingPhase 3
A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
Janssen Research & Development, LLC
- Location
- Park Ridge, IL + 19 other US sites
- Eligibility basics
- Ages 18–45 · Women only
- RecruitingPhase 3
A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
Janssen Research & Development, LLC
- Location
- Park Ridge, IL + 11 other US sites
- Eligibility basics
- Ages 18–45 · Women only
- RecruitingPhase 3
Brexanolone Lifting Outcomes Of Moms
Lipocine Inc.
- Location
- Chicago, IL + 15 other US sites
- Eligibility basics
- Ages 15–45 · Women only
- Recruiting
Prenatal Study in Healthy Pregnant Women
Perelel Inc.
- Location
- Chicago, IL
- Eligibility basics
- Ages 21–40 · Women only